ClearPoint Neuro Inc. (CLPT)
undefined
undefined%
At close: undefined
15.68
2.28%
After-hours Dec 13, 2024, 07:54 PM EST

Company Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States.

The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance.

It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite.

It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco.

The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020.

ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

ClearPoint Neuro Inc.
ClearPoint Neuro Inc. logo
Country United States
IPO Date May 22, 2012
Industry Medical - Devices
Sector Healthcare
Employees 107
CEO Joseph Michael Burnett

Contact Details

Address:
120 S. Sierra Avenue
Solana Beach, California
United States
Website https://www.clearpointneuro.com

Stock Details

Ticker Symbol CLPT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001285550
CUSIP Number 18507C103
ISIN Number US18507C1036
Employer ID 58-2394628
SIC Code 3841

Key Executives

Name Position
Joseph Michael Burnett President, Chief Executive Officer & Director
Danilo D'Alessandro Chief Financial Officer
Mazin Sabra Chief Operating Officer
Ellisa Cholapranee J.D. General Counsel & Secretary
Jacqueline Keller Vice President of Marketing
Jeremy Stigall Chief Business Officer

Latest SEC Filings

Date Type Title
Nov 12, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 08, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 07, 2024 8-K Current Report
Nov 07, 2024 424B5 Filing
Nov 07, 2024 10-Q Quarterly Report
Nov 07, 2024 8-K Current Report
Nov 04, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Oct 11, 2024 4 Filing
Oct 02, 2024 4 Filing
Oct 02, 2024 4 Filing